0 Commentaires
0 Parts
651 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Marketplace
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Bacillus Calmette-Guerin (BCG) Vaccine Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Executive Summary Bacillus Calmette-Guerin (BCG) Vaccine Market Size and Share Across Top Segments The global Bacillus Calmette-Guerin (BCG) vaccine market size was valued at USD 61.84 billion in 2024 and is expected to reach USD 92.06 billion by 2032, at a CAGR of 5.10% during the forecast periodThe market growth is primarily driven by the ongoing global efforts to control...0 Commentaires 0 Parts 168 Vue 0 Aperçu
-
Bacillus Calmette-Guerin (BCG) Vaccine Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Executive Summary Bacillus Calmette-Guerin (BCG) Vaccine Market Market Size and Share Forecast The global Bacillus Calmette-Guerin (BCG) vaccine market size was valued at USD 61.84 billion in 2024 and is expected to reach USD 92.06 billion by 2032, at a CAGR of 5.10% during the forecast periodThe market growth is primarily driven by the ongoing global efforts to control tuberculosis...0 Commentaires 0 Parts 362 Vue 0 Aperçu
-
Global Vaccine Adjuvants Market Industry – Key Players, Size, Trends, Opportunities, Growth- Analysis to 2025-2034The market research for the global Vaccine Adjuvants market is an accumulation of first-hand facts and quantitative and qualitative evaluation and analysis for the forecast period (2024-2032). The report offers a comprehensive assessment of macro-economic indicators, parent market trends, and several factors influencing the market dynamics. In addition, it also assesses the...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Ad5-nCoV Vaccine Market Growth & CAGR 12.5% ForecastAccording to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...0 Commentaires 0 Parts 26 Vue 0 Aperçu
-
Ad5-nCoV Vaccine Market Growth & CAGR 12.5% ForecastAccording to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...0 Commentaires 0 Parts 28 Vue 0 Aperçu
-
Diphtheria, Tetanus and Pertussis Vaccine Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Diphtheria, Tetanus and Pertussis Vaccine Market : The global diphtheria, tetanus and pertussis vaccine market size was valued at USD 6.01 billion in 2024 and is projected to reach USD 9.75 billion by 2032, with a CAGR of 6.23% during the forecast period of 2025 to 2032. The Diphtheria, Tetanus and Pertussis Vaccine Market research report delivers...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Human Papillomavirus Vaccine (HPV) Market Valuation to Touch US$ 7.71 Billion by 2034The Human Papillomavirus (HPV) Vaccine is formulated using virus-like particles that mimic the outer protein structure of the virus without containing its genetic material. This design ensures strong immunogenicity while maintaining a high safety profile. By targeting specific high-risk and low-risk HPV strains, the vaccine effectively prevents infections that may otherwise progress to...0 Commentaires 0 Parts 999 Vue 0 Aperçu
-
Market Outlook Report: Hepatitis B Therapeutics Demand, Forecast & OpportunitiesHepatitis B therapeutics are medical treatments used to suppress the hepatitis B virus and protect liver cells. They are critical in preventing disease progression. Regular follow-up is important. Hepatitis B Therapeutics Market Overview The Hepatitis B Therapeutics Market is projected to reach US$ 7.26 billion by 2031, growing at a CAGR of 8.8% during the forecast period from 2025 to...0 Commentaires 1 Parts 1KB Vue 0 Aperçu
-
Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...0 Commentaires 0 Parts 460 Vue 0 Aperçu
-
Oral Vaccine Market Opportunities: Growth, Share, Value, Size, and Scope"Latest Insights on Executive Summary Oral Vaccine Market Share and Size The global oral vaccine market size was valued at USD 4.29 billion in 2025 and is expected to reach USD 7.48 billion by 2033, at a CAGR of 7.20% during the forecast period The market insights gained through this keyword market research analysis report facilitate a more defined...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Smart Glasses Market Revenue Analysis: Growth, Share, Value, Size, and Insights"Executive Summary Smart Glasses Market : Smart glasses market will grow at a rate of 12.00% for the forecast period of 2021 to 2028. Smart glasses market report analyses the growth, which is currently being growing due to rising demand for smart glass in automobile applications Smart Glasses Market analysis report is a professional and a detailed market study focusing on primary...0 Commentaires 0 Parts 14KB Vue 0 Aperçu
Plus de résultats
Commandité
Commandité
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek